Granules India announced that the US FDA hasapproved its Abbreviated New Drug Application (ANDA) for Acetaminophen 650 mg Tablets,Extended Release, bioequivalent to the reference listed drug product (RiD), Tylenol 650mgtablets, Extended Release. The ANDA was filed by Granules Pharmaceuticals Inc, a whollyowned subsidiary of Granules lndia.

Acetaminophen 650 mg extended release tablets are. used primarily for temporary painmanagement including arthritis relief


0 thoughts on “Granules India receives USFDA approval for Acetaminophen 650 mg Tablets”

Post Comment

  SureShot Intraday Performance

Sure Shot Intraday performance will be given usually at any time of the trading day whenever the trend occurs in market.

View My Stats